Kidney Health-Focused Vera Therapeutics Stock Price Spikes On Heels Of Successful Trial Data

benzinga.com/news/health-care/25/06/45720783/kidney-health-focused-vera-therapeutics-stock-price-spikes-on-heels-of-successful-trial-data

Vera Therapeutics, Inc. (NASDAQ:VERA) saw its share price surge over 65% during the pre-market trading session on Monday after the company released ORIGIN Phase 3 trial data.
Participants treated with atacicept for immunoglobulin A nephropathy (IgAN) achieved a 46% reduction from…

This story appeared on benzinga.com, 2025-06-02 13:01:22.
The Entire Business World on a Single Page. Free to Use →